APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Obesity Prescription

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Obesity Prescription Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchAnti-Obesity Prescription Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Obesity Prescription Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Anti-Obesity Prescription Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Obesity Prescription Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Obesity Prescription Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Anti-Obesity Prescription market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Obesity Prescription is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Obesity Prescription is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Obesity Prescription is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Obesity Prescription include Akrimax Pharmaceuticals, Alpex Pharma, Arena Pharmaceuticals, Arrowhead Research, Bridge BioResearch, Compellis Pharmaceuticals, Yungjin Pharm, Zealand Pharma and Zydus Cadila, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Obesity Prescription market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Obesity Prescription market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Obesity Prescription market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Obesity Prescription.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Obesity Prescription market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Obesity Prescription Market by Company

Akrimax Pharmaceuticals

Alpex Pharma

Arena Pharmaceuticals

Arrowhead Research

Bridge BioResearch

Compellis Pharmaceuticals

Yungjin Pharm

Zealand Pharma

Zydus Cadila

Anti-Obesity Prescription Segment by Type

Lorcaserin

Liraglutide

Phentermine and Topiramate

Orlistat

Bupropion and Naltrexone

Anti-Obesity Prescription Segment by Application

E-Commerce

Retail Pharmacies

Hospital Pharmacies

Anti-Obesity Prescription Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Obesity Prescription market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Obesity Prescription and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Obesity Prescription.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Obesity Prescription manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Obesity Prescription in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lorcaserin Table 2. Major Company of Liraglutide Table 3. Major Company of Phentermine and Topiramate Table 4. Major Company of Orlistat Table 5. Major Company of Bupropion and Naltrexone Table 6. Global Anti-Obesity Prescription Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 8. Global Anti-Obesity Prescription Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti-Obesity Prescription Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti-Obesity Prescription Price by Type (2021-2026) & (US$/unit) Table 12. Global Anti-Obesity Prescription Sales by Type (2027-2032) & (k units) Table 13. Global Anti-Obesity Prescription Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti-Obesity Prescription Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti-Obesity Prescription Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti-Obesity Prescription Price by Type (2027-2032) & (US$/unit) Table 17. North America Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 18. North America Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 20. Europe Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 24. Latin America Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti-Obesity Prescription Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Anti-Obesity Prescription Sales by Type (2021-2026) & (US$ Million) Table 27. Anti-Obesity Prescription Industry Trends Table 28. Anti-Obesity Prescription Industry Drivers Table 29. Anti-Obesity Prescription Industry Opportunities and Challenges Table 30. Anti-Obesity Prescription Industry Restraints Table 31. Global Anti-Obesity Prescription Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti-Obesity Prescription Revenue Market Share by Company (2021-2026) Table 33. Global Anti-Obesity Prescription Sales by Company (2021-2026) & (k units) Table 34. Global Anti-Obesity Prescription Sales Share by Company (2021-2026) Table 35. Global Anti-Obesity Prescription Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Anti-Obesity Prescription Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti-Obesity Prescription Major Company Production Sites and Headquarters Table 38. Global Anti-Obesity Prescription Company, Product Type & Application Table 39. Global Anti-Obesity Prescription Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti-Obesity Prescription by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti-Obesity Prescription Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti-Obesity Prescription Sales by Region (2021-2026) & (k units) Table 44. Global Anti-Obesity Prescription Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti-Obesity Prescription Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti-Obesity Prescription Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti-Obesity Prescription Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Anti-Obesity Prescription Sales by Region (2027-2032) & (k units) Table 49. Global Anti-Obesity Prescription Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti-Obesity Prescription Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti-Obesity Prescription Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti-Obesity Prescription Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Anti-Obesity Prescription Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 55. Global Anti-Obesity Prescription Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti-Obesity Prescription Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti-Obesity Prescription Price by Application (2021-2026) & (US$/unit) Table 59. Global Anti-Obesity Prescription Sales by Application (2027-2032) & (k units) Table 60. Global Anti-Obesity Prescription Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti-Obesity Prescription Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti-Obesity Prescription Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti-Obesity Prescription Price by Application (2027-2032) & (US$/unit) Table 64. North America Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 65. North America Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 67. Europe Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 71. Latin America Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti-Obesity Prescription Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Anti-Obesity Prescription Sales by Application (2021-2026) & (US$ Million) Table 74. Akrimax Pharmaceuticals Company Information Table 75. Akrimax Pharmaceuticals Business Overview Table 76. Akrimax Pharmaceuticals Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Akrimax Pharmaceuticals Anti-Obesity Prescription Product Portfolio Table 78. Akrimax Pharmaceuticals Recent Development Table 79. Alpex Pharma Company Information Table 80. Alpex Pharma Business Overview Table 81. Alpex Pharma Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Alpex Pharma Anti-Obesity Prescription Product Portfolio Table 83. Alpex Pharma Recent Development Table 84. Arena Pharmaceuticals Company Information Table 85. Arena Pharmaceuticals Business Overview Table 86. Arena Pharmaceuticals Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Arena Pharmaceuticals Anti-Obesity Prescription Product Portfolio Table 88. Arena Pharmaceuticals Recent Development Table 89. Arrowhead Research Company Information Table 90. Arrowhead Research Business Overview Table 91. Arrowhead Research Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Arrowhead Research Anti-Obesity Prescription Product Portfolio Table 93. Arrowhead Research Recent Development Table 94. Bridge BioResearch Company Information Table 95. Bridge BioResearch Business Overview Table 96. Bridge BioResearch Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Bridge BioResearch Anti-Obesity Prescription Product Portfolio Table 98. Bridge BioResearch Recent Development Table 99. Compellis Pharmaceuticals Company Information Table 100. Compellis Pharmaceuticals Business Overview Table 101. Compellis Pharmaceuticals Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Compellis Pharmaceuticals Anti-Obesity Prescription Product Portfolio Table 103. Compellis Pharmaceuticals Recent Development Table 104. Yungjin Pharm Company Information Table 105. Yungjin Pharm Business Overview Table 106. Yungjin Pharm Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Yungjin Pharm Anti-Obesity Prescription Product Portfolio Table 108. Yungjin Pharm Recent Development Table 109. Zealand Pharma Company Information Table 110. Zealand Pharma Business Overview Table 111. Zealand Pharma Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Zealand Pharma Anti-Obesity Prescription Product Portfolio Table 113. Zealand Pharma Recent Development Table 114. Zydus Cadila Company Information Table 115. Zydus Cadila Business Overview Table 116. Zydus Cadila Anti-Obesity Prescription Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Zydus Cadila Anti-Obesity Prescription Product Portfolio Table 118. Zydus Cadila Recent Development Table 119. North America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Anti-Obesity Prescription Sales by Country (2021-2026) & (k units) Table 121. North America Anti-Obesity Prescription Sales Market Share by Country (2021-2026) Table 122. North America Anti-Obesity Prescription Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Anti-Obesity Prescription Sales Market Share Forecast by Country (2027-2032) Table 124. North America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Anti-Obesity Prescription Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Anti-Obesity Prescription Market Share by Country (2021-2026) Table 127. North America Anti-Obesity Prescription Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Anti-Obesity Prescription Market Share Forecast by Country (2027-2032) Table 129. Europe Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Anti-Obesity Prescription Sales by Country (2021-2026) & (k units) Table 131. Europe Anti-Obesity Prescription Sales Market Share by Country (2021-2026) Table 132. Europe Anti-Obesity Prescription Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Anti-Obesity Prescription Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Anti-Obesity Prescription Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Anti-Obesity Prescription Market Share by Country (2021-2026) Table 137. Europe Anti-Obesity Prescription Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Anti-Obesity Prescription Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Anti-Obesity Prescription Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Anti-Obesity Prescription Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Anti-Obesity Prescription Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Anti-Obesity Prescription Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Anti-Obesity Prescription Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Anti-Obesity Prescription Market Share by Country (2021-2026) Table 147. Asia-Pacific Anti-Obesity Prescription Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Anti-Obesity Prescription Market Share Forecast by Country (2027-2032) Table 149. Latin America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Anti-Obesity Prescription Sales by Country (2021-2026) & (k units) Table 151. Latin America Anti-Obesity Prescription Sales Market Share by Country (2021-2026) Table 152. Latin America Anti-Obesity Prescription Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Anti-Obesity Prescription Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Anti-Obesity Prescription Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Anti-Obesity Prescription Market Share by Country (2021-2026) Table 157. Latin America Anti-Obesity Prescription Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Anti-Obesity Prescription Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Anti-Obesity Prescription Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Anti-Obesity Prescription Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Anti-Obesity Prescription Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Anti-Obesity Prescription Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Anti-Obesity Prescription Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Anti-Obesity Prescription Market Share by Country (2021-2026) Table 167. Middle East and Africa Anti-Obesity Prescription Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Anti-Obesity Prescription Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Anti-Obesity Prescription Distributors List Table 172. Anti-Obesity Prescription Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Anti-Obesity Prescription Image Figure 2. Global Anti-Obesity Prescription Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Obesity Prescription Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Obesity Prescription Sales (2021-2032) & (k units) Figure 5. Lorcaserin Image Figure 6. Global Lorcaserin Sales YoY Growth (2021-2032) & (k units) Figure 7. Liraglutide Image Figure 8. Global Liraglutide Sales YoY Growth (2021-2032) & (k units) Figure 9. Phentermine and Topiramate Image Figure 10. Global Phentermine and Topiramate Sales YoY Growth (2021-2032) & (k units) Figure 11. Orlistat Image Figure 12. Global Orlistat Sales YoY Growth (2021-2032) & (k units) Figure 13. Bupropion and Naltrexone Image Figure 14. Global Bupropion and Naltrexone Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Anti-Obesity Prescription Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti-Obesity Prescription Market Share by Type 2025 VS 2032 Figure 17. North America Anti-Obesity Prescription Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti-Obesity Prescription Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti-Obesity Prescription Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti-Obesity Prescription Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti-Obesity Prescription Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti-Obesity Prescription Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti-Obesity Prescription Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti-Obesity Prescription Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti-Obesity Prescription Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti-Obesity Prescription Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti-Obesity Prescription Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. E-Commerce Image Figure 30. Global E-Commerce Sales YoY Growth (2021-2032) & (k units) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Anti-Obesity Prescription Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Anti-Obesity Prescription Market Share by Application 2025 VS 2032 Figure 37. North America Anti-Obesity Prescription Sales Market Share in Volume by Application in 2025 Figure 38. North America Anti-Obesity Prescription Sales Market Share in Value by Application in 2025 Figure 39. Europe Anti-Obesity Prescription Sales Market Share in Volume by Application in 2025 Figure 40. Europe Anti-Obesity Prescription Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Anti-Obesity Prescription Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Anti-Obesity Prescription Sales Market Share in Value by Application in 2025 Figure 43. Latin America Anti-Obesity Prescription Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Anti-Obesity Prescription Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Anti-Obesity Prescription Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Anti-Obesity Prescription Sales Market Share in Value by Application in 2025 Figure 47. North America Anti-Obesity Prescription Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Anti-Obesity Prescription Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Anti-Obesity Prescription Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Anti-Obesity Prescription Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Obesity Prescription Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Anti-Obesity Prescription Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti-Obesity Prescription Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Anti-Obesity Prescription Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Obesity Prescription Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Anti-Obesity Prescription Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti-Obesity Prescription Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Anti-Obesity Prescription Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Obesity Prescription Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Anti-Obesity Prescription Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti-Obesity Prescription Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Anti-Obesity Prescription Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Obesity Prescription Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Anti-Obesity Prescription Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti-Obesity Prescription Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Anti-Obesity Prescription Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-Obesity Prescription Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Anti-Obesity Prescription Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lorcaserin
  • Liraglutide
  • Phentermine and Topiramate
  • Orlistat
  • Bupropion and Naltrexone
Applications
  • E-Commerce
  • Retail Pharmacies
  • Hospital Pharmacies
Companies covered
  • Akrimax Pharmaceuticals
  • Alpex Pharma
  • Arena Pharmaceuticals
  • Arrowhead Research
  • Bridge BioResearch
  • Compellis Pharmaceuticals
  • Yungjin Pharm
  • Zealand Pharma
  • Zydus Cadila

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Obesity Prescription Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Obesity Prescription Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Obesity Prescription Market by Type
  6. 1.3.1 Lorcaserin
  7. 1.3.2 Liraglutide
  8. 1.3.3 Phentermine and Topiramate
  9. 1.3.4 Orlistat
  10. 1.3.5 Bupropion and Naltrexone
  11. 1.4 Global Anti-Obesity Prescription Market Size by Type
  12. 1.4.1 Global Anti-Obesity Prescription Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti-Obesity Prescription Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti-Obesity Prescription Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti-Obesity Prescription Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti-Obesity Prescription Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti-Obesity Prescription Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti-Obesity Prescription Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti-Obesity Prescription Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Obesity Prescription Industry Trends
  2. 2.2 Anti-Obesity Prescription Industry Drivers
  3. 2.3 Anti-Obesity Prescription Industry Opportunities and Challenges
  4. 2.4 Anti-Obesity Prescription Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Obesity Prescription Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Obesity Prescription Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Obesity Prescription Price (2021-2026)
  4. 3.4 Global Anti-Obesity Prescription Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Obesity Prescription Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Obesity Prescription Company, Product Type & Application
  7. 3.7 Global Anti-Obesity Prescription Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Obesity Prescription Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Obesity Prescription Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Obesity Prescription Tier 1, Tier 2, and Tier 3
4 Anti-Obesity Prescription Regional Status and Outlook
  1. 4.1 Global Anti-Obesity Prescription Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Obesity Prescription Historic Market Size by Region
  3. 4.2.1 Global Anti-Obesity Prescription Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Obesity Prescription Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Obesity Prescription Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Obesity Prescription Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Obesity Prescription Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Obesity Prescription Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Obesity Prescription Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Obesity Prescription by Application
  1. 5.1 Anti-Obesity Prescription Market by Application
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Anti-Obesity Prescription Market Size by Application
  6. 5.2.1 Global Anti-Obesity Prescription Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti-Obesity Prescription Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti-Obesity Prescription Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti-Obesity Prescription Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti-Obesity Prescription Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti-Obesity Prescription Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti-Obesity Prescription Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti-Obesity Prescription Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akrimax Pharmaceuticals
  2. 6.1.1 Akrimax Pharmaceuticals Company Information
  3. 6.1.2 Akrimax Pharmaceuticals Business Overview
  4. 6.1.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akrimax Pharmaceuticals Anti-Obesity Prescription Product Portfolio
  6. 6.1.5 Akrimax Pharmaceuticals Recent Developments
  7. 6.2 Alpex Pharma
  8. 6.2.1 Alpex Pharma Company Information
  9. 6.2.2 Alpex Pharma Business Overview
  10. 6.2.3 Alpex Pharma Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alpex Pharma Anti-Obesity Prescription Product Portfolio
  12. 6.2.5 Alpex Pharma Recent Developments
  13. 6.3 Arena Pharmaceuticals
  14. 6.3.1 Arena Pharmaceuticals Company Information
  15. 6.3.2 Arena Pharmaceuticals Business Overview
  16. 6.3.3 Arena Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Arena Pharmaceuticals Anti-Obesity Prescription Product Portfolio
  18. 6.3.5 Arena Pharmaceuticals Recent Developments
  19. 6.4 Arrowhead Research
  20. 6.4.1 Arrowhead Research Company Information
  21. 6.4.2 Arrowhead Research Business Overview
  22. 6.4.3 Arrowhead Research Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Arrowhead Research Anti-Obesity Prescription Product Portfolio
  24. 6.4.5 Arrowhead Research Recent Developments
  25. 6.5 Bridge BioResearch
  26. 6.5.1 Bridge BioResearch Company Information
  27. 6.5.2 Bridge BioResearch Business Overview
  28. 6.5.3 Bridge BioResearch Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bridge BioResearch Anti-Obesity Prescription Product Portfolio
  30. 6.5.5 Bridge BioResearch Recent Developments
  31. 6.6 Compellis Pharmaceuticals
  32. 6.6.1 Compellis Pharmaceuticals Company Information
  33. 6.6.2 Compellis Pharmaceuticals Business Overview
  34. 6.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Compellis Pharmaceuticals Anti-Obesity Prescription Product Portfolio
  36. 6.6.5 Compellis Pharmaceuticals Recent Developments
  37. 6.7 Yungjin Pharm
  38. 6.7.1 Yungjin Pharm Company Information
  39. 6.7.2 Yungjin Pharm Business Overview
  40. 6.7.3 Yungjin Pharm Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yungjin Pharm Anti-Obesity Prescription Product Portfolio
  42. 6.7.5 Yungjin Pharm Recent Developments
  43. 6.8 Zealand Pharma
  44. 6.8.1 Zealand Pharma Company Information
  45. 6.8.2 Zealand Pharma Business Overview
  46. 6.8.3 Zealand Pharma Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zealand Pharma Anti-Obesity Prescription Product Portfolio
  48. 6.8.5 Zealand Pharma Recent Developments
  49. 6.9 Zydus Cadila
  50. 6.9.1 Zydus Cadila Company Information
  51. 6.9.2 Zydus Cadila Business Overview
  52. 6.9.3 Zydus Cadila Anti-Obesity Prescription Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zydus Cadila Anti-Obesity Prescription Product Portfolio
  54. 6.9.5 Zydus Cadila Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Obesity Prescription Sales by Country
  2. 7.1.1 North America Anti-Obesity Prescription Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Obesity Prescription Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Obesity Prescription Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Obesity Prescription Market Size by Country
  6. 7.2.1 North America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Obesity Prescription Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Obesity Prescription Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Obesity Prescription Sales by Country
  2. 8.1.1 Europe Anti-Obesity Prescription Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Obesity Prescription Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Obesity Prescription Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Obesity Prescription Market Size by Country
  6. 8.2.1 Europe Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Obesity Prescription Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Obesity Prescription Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Obesity Prescription Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Obesity Prescription Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Obesity Prescription Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Obesity Prescription Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Obesity Prescription Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Obesity Prescription Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Obesity Prescription Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Obesity Prescription Sales by Country
  2. 10.1.1 South America Anti-Obesity Prescription Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Obesity Prescription Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Obesity Prescription Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Obesity Prescription Market Size by Country
  6. 10.2.1 South America Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Obesity Prescription Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Obesity Prescription Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Obesity Prescription Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Obesity Prescription Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Obesity Prescription Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Obesity Prescription Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Obesity Prescription Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Obesity Prescription Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Obesity Prescription Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Obesity Prescription Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Obesity Prescription Value Chain Analysis
  2. 12.1.1 Anti-Obesity Prescription Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Obesity Prescription Production Mode & Process
  7. 12.2 Anti-Obesity Prescription Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Obesity Prescription Distributors
  10. 12.2.3 Anti-Obesity Prescription Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst